Walgreens records $5.8B impairment charge for VillageMD clinic value drop in Q2.

Walgreens reports $6B loss in Q2 due to VillageMD clinic value drop. Excluding this charge, the company's results beat Wall Street expectations. Walgreens spent over $5B to acquire a majority stake in VillageMD in 2018, intending to expand its healthcare services. The company recorded a $5.8B after-tax impairment charge for VillageMD in the most recent quarter as it adjusted the asset's value, reflecting the struggling healthcare business.

March 28, 2024
21 Articles

Further Reading